Published in Expert Rev Med Devices on January 01, 2011
MitraClip System in Australia and New Zealand (MitraClipANZ) | NCT01301625
Contractile mitral annular forces are reduced with ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2012) 0.89
Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J Am Coll Cardiol (2006) 1.62
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv (2009) 1.61
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke (2009) 1.58
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. JACC Cardiovasc Interv (2009) 1.52
Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation. Int J Cardiol (2010) 1.50
Impact of a dedicated training program on the reproducibility of systolic dyssynchrony measures using tissue Doppler imaging. J Am Soc Echocardiogr (2011) 1.46
Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry. Eur J Heart Fail (2011) 1.41
Unusual case of recurrent renal artery stenosis: lessons to learn. Kidney Int (2008) 1.40
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol (2010) 1.39
Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv (2011) 1.37
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today (2010) 1.24
Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv (2011) 1.20
Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv (2010) 1.12
Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population. Clin Ther (2011) 1.10
Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2011) 1.07
Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation. Nephrology (Carlton) (2012) 0.98
Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model. Int J Cardiol (2013) 0.97
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J (2009) 0.96
Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. Eur Heart J (2003) 0.95
Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. JACC Cardiovasc Imaging (2009) 0.93
Role of warfarin pharmacogenetic testing in clinical practice. Pharmacogenomics (2010) 0.92
Images in cardiovascular medicine. Giant left circumflex coronary artery aneurysm with arteriovenous fistula to the coronary sinus. Circulation (2008) 0.90
Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol (2013) 0.90
Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy? Am J Cardiol (2006) 0.89
Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol (2007) 0.89
The mystery of coronary artery spasm. Heart Lung Circ (2006) 0.87
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions? Br J Clin Pharmacol (2011) 0.87
Coil embolization of an iatrogenic coronary artery to cardiac vein fistula after rotational atherectomy. J Interv Cardiol (2008) 0.86
Marantic endocarditis presenting as recurrent arterial embolisation. Int J Cardiol (2007) 0.86
Measuring health related quality of life in coronary heart disease: the importance of feeling well. Int J Cardiol (2010) 0.86
Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv (2013) 0.85
Quality of life after percutaneous coronary intervention in the elderly with acute coronary syndrome. Int J Cardiol (2010) 0.85
Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm. Cardiovasc Hematol Agents Med Chem (2009) 0.85
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease. Clin Cardiol (2013) 0.84
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol (2010) 0.84
Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure. Int J Cardiol (2007) 0.84
Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. Cardiovasc Res (2013) 0.83
Relation of left ventricular systolic dyssynchrony in patients with heart failure to left ventricular ejection fraction and to QRS duration. Am J Cardiol (2008) 0.83
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data. Thromb Haemost (2015) 0.83
Incidence and prognosis of vascular complications after transcatheter aortic valve implantation. J Vasc Surg (2013) 0.83
The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome. Clin Cardiol (2011) 0.83
An armband wearable device for overnight and cuff-less blood pressure measurement. IEEE Trans Biomed Eng (2014) 0.82
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data. Pharmacol Ther (2010) 0.82
Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong. Clin Cardiol (2012) 0.82
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry. Med J Aust (2008) 0.81
Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension. PLoS One (2013) 0.81
Attenuation of systolic blood pressure and pulse transit time hysteresis during exercise and recovery in cardiovascular patients. IEEE Trans Biomed Eng (2014) 0.80
Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials. Cardiovasc Drugs Ther (2013) 0.80
Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel. Pharmacol Ther (2009) 0.80
Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting. Cardiovasc Hematol Agents Med Chem (2008) 0.80
Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited. Int J Cardiol (2012) 0.80
Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions. EuroIntervention (2009) 0.79
Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med (2009) 0.79
Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting. J Gastroenterol Hepatol (2010) 0.79
Management of access site and systemic complications of percutaneous coronary and peripheral interventions. J Invasive Cardiol (2008) 0.79
Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong. Clin Cardiol (2012) 0.79
The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosis. EuroIntervention (2006) 0.79
Renal artery revascularization: collaborative approaches for specialists. Adv Chronic Kidney Dis (2008) 0.78
Wearable cuff-less PTT-based system for overnight blood pressure monitoring. Conf Proc IEEE Eng Med Biol Soc (2013) 0.78
Effect of age and heart rate on atrial mechanical function assessed by Doppler tissue imaging in healthy individuals. J Am Soc Echocardiogr (2006) 0.78
Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control study. Vasc Med (2009) 0.78
Changes of ventricular and peripheral performance in patients with heart failure and normal ejection fraction: insights from ergometry stress echocardiography. Eur J Heart Fail (2014) 0.78
Cardiovascular medication use following percutaneous coronary intervention: the Australian experience. Cardiovasc Ther (2014) 0.77
Enhanced detection of patent foramen ovale by systematic transthoracic saline contrast echocardiography. Int J Cardiol (2010) 0.77
The no-reflow phenomenon in the coronary circulation. Cardiovasc Hematol Agents Med Chem (2009) 0.77
Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome. Cardiovasc Ther (2011) 0.77
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation--a real patient data analysis in a Hong Kong teaching hospital. Clin Cardiol (2013) 0.77
A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. Int J Lab Hematol (2008) 0.77
An objective and reproducible method for quantification of aortic regurgitation after TAVI. EuroIntervention (2014) 0.76
Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Heart Lung Circ (2007) 0.76
Treatment of renal artery in-stent restenosis with sirolimus-eluting stents. Vasc Med (2009) 0.76
Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances. J Basic Clin Physiol Pharmacol (2017) 0.75
What's Old is New Again - A review of the current evidence of colchicine in cardiovascular medicine. Curr Cardiol Rev (2016) 0.75
Coherence analysis of invasive blood pressure and its noninvasive indicators for improvement of cuffless measurement accuracy. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat". Tech Vasc Interv Radiol (2010) 0.75
Protection devices and thrombectomy for native coronary artery ST-elevation myocardial infarction. J Invasive Cardiol (2008) 0.75
Images in cardiovascular medicine. Adventitial fibromuscular dysplasia of the renal artery: management challenges of nonatherosclerotic renal artery stenosis. Circulation (2009) 0.75
Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting. Int J Cardiol (2012) 0.75
Clinical manifestation and current management of patent foramen ovale. Expert Rev Cardiovasc Ther (2009) 0.75
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry. Int J Cardiol (2013) 0.75
How to plan an Overlap Free Projection on CTA or fluoroscopy to facilitate quantitative analysis. EuroIntervention (2017) 0.75
Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease. J Vasc Surg (2009) 0.75
Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis. Cardiovasc Hematol Agents Med Chem (2009) 0.75
Noninvasive Characterization of Vascular Tone by Model-Based System Identification in Healthy and Heart Failure Patients. Ann Biomed Eng (2015) 0.75
Left atrial remodeling and reduced atrial pump function after chronic right ventricular apical pacing in patients with preserved ejection fraction. Int J Cardiol (2011) 0.75
Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome. Expert Opin Drug Metab Toxicol (2012) 0.75
Perioperative rupture of the LIMA graft leading to cardiogenic shock, emergency angiography, and stenting with a polytetrafluoroethylene-covered stent. Catheter Cardiovasc Interv (2011) 0.75